EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preoperative alpha fetoprotein, total bilirubin, fibrinogen, albumin, and lymphocytes predict postoperative survival in hepatocellular carcinoma

Jia Xu, Shu An, Ying Lu, Laisheng Li, Zhi-Qi Wu, Hua-Guo Xu iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.6030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Jia Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Our study focused on exploring the feasible prognostic laboratory parameters of HCC and establishing a score model to estimate individualized overall survival (OS) in HCC after resection.

Methods

Four hundred and sixty‐one patients with HCC who underwent hepatectomy between January 2010 and December 2017 was enrolled in this investigation. Cox proportional hazards model was conducted to analyze the prognostic value of laboratory parameters. The score model construction was based on the forest plot results. Overall survival was evaluated by Kaplan‐Meier method and the log‐rank test. The novel score model was validated in an external validation cohort from a different medical institution.

Results

We identified that alpha fetoprotein (AFP), total bilirubin (TB), fibrinogen (FIB), albumin (ALB), and lymphocyte (LY) were independent prognostic factors. High AFP, TB, FIB (HR > 1, p < 0.05), and low ALB, LY (HR < 1, p < 0.05) were associated with the survival of HCC. The novel score model of OS based on these five independent prognostic factors achieved high C‐index of 0.773 (95% confidence interval [CI]: 0.738–0.808), which was significantly higher than those of the single five independent factors (0.572–0.738). The score model was validated in the external cohort whose C‐index was 0.7268 (95% CI: 0.6744–0.7792).

Conclusion

The novel score model we established was an easy‐to‐use tool which could enable individualized estimation of OS in patients with HCC who underwent curative hepatectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansalpha-FetoproteinsFibrinogenBilirubinPrognosisAlbuminsHepatectomyLymphocytesRetrospective Studies

Stichwörter der Autor:innen

hepatocellular carcinomaoverall survivalprognosisscore model

Substanzen

alpha-FetoproteinsFibrinogenBilirubinAlbumins

Autor:innen und Institutionen

  • Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Branch of National Clinical Research Center for Laboratory Medicine, Nanjing, Jiangsu, China.
  • Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

ORCID-Profile: Hua-Guo Xu

Förderung

  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Xu, J., An, S., Lu, Y., Li, L., Wu, Z. Q., & Xu, H. G. (2023). Preoperative alpha fetoprotein, total bilirubin, fibrinogen, albumin, and lymphocytes predict postoperative survival in hepatocellular carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.6030

Vancouver

Xu J, An S, Lu Y, Li L, Wu ZQ, Xu HG. Preoperative alpha fetoprotein, total bilirubin, fibrinogen, albumin, and lymphocytes predict postoperative survival in hepatocellular carcinoma. Cancer Medicine. 2023. doi:10.1002/cam4.6030

BibTeX
@article{Xu2023,
  author = {Xu, Jia and An, Shu and Lu, Ying and Li, Laisheng and Wu, Zhi-Qi and Xu, Hua-Guo},
  title = {Preoperative alpha fetoprotein, total bilirubin, fibrinogen, albumin, and lymphocytes predict postoperative survival in hepatocellular carcinoma},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6030}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche